Qian Zeng
Key Laboratory Of Clinical Laboratory Diagnostics, No.1, Yixueyuan Road
Chongqing, 400016, China
Chongqing, 400016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Mitochondrial pyruvate dehydrogenase kinase 1 drives bevacizumab resistance and malignant phenotype of TNBC by enhancing mitophagy.
Journal: Pharmacological research
Published: September 03, 2025
Dual-aptamer-engineered M1 macrophage with enhanced specific targeting and checkpoint blocking for solid-tumor immunotherapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 21, 2024
Corrigendum: Identification of differentially expressed hub genes associated with immune cell recruitment in claudin-low breast cancer.
Journal: Frontiers in oncology
Published: November 09, 2023
TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs.
Journal: Molecular therapy. Oncology
Published: September 26, 2023
PDK1-stabilized LncRNA SPRY4-IT1 promotes breast cancer progression via activating NF-κB signaling pathway.
Journal: Molecular carcinogenesis
Published: December 18, 2022
Correction to: Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8+ T cell exclusion.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 13, 2022
Dual-aptamer-engineered M1 macrophage with enhanced specific targeting and checkpoint blocking for solid-tumor immunotherapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 21, 2022
Identification of Differentially Expressed Hub Genes Associated With Immune Cell Recruitment in Claudin-Low Breast Cancer.
Journal: Frontiers in oncology
Published: January 21, 2022
Dual-Targeted Self-Assembled DNA Hydrogels Decorated With Multivalent Aptamers Loaded With DOX for Anticancer Therapy.
Journal: Frontiers in pharmacology
Published: November 11, 2021
The miR-345-3p/PPP2CA signaling axis promotes proliferation and invasion of breast cancer cells.
Journal: Carcinogenesis
Published: October 14, 2021
Last Updated: 09/26/2026